Skip to main content
logo
Esperion Therapeutics, Inc. (ESPR)
Jul 13, 2026 - ESPR was delisted
3.180
-0.010 (-0.31%)
Inactive · Last trade price on Jul 10, 2026

Esperion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
819871433340459306
Market Cap Growth
305.27%100.95%27.49%-25.93%49.97%-57.77%
Enterprise Value
1,2071,380848757815726
Last Close Price
3.183.702.202.996.235.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-12.2616.60---
PS Ratio
1.962.161.302.926.083.90
PB Ratio
--2.88-1.11-0.75-1.42-1.55

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.893.422.556.5110.799.26
EV/EBITDA Ratio
15.9122.8515.58---
EV/EBIT Ratio
15.9322.8915.59---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.77-1.81-1.52-1.19-1.56-2.63
Debt / EBITDA Ratio
6.948.7010.29---
Net Debt / Equity Ratio
-1.26-1.26-1.15-1.01-1.04-1.31
Net Debt / EBITDA Ratio
5.116.308.20-2.95-1.89-1.21
Net Debt / FCF Ratio
-21.09-29.03-18.62-3.39-1.93-0.98
Asset Turnover
1.061.001.210.510.240.21
Inventory Turnover
1.371.391.322.574.194.76
Quick Ratio
0.961.020.910.842.173.85
Current Ratio
1.531.541.371.292.674.49
Return on Assets (ROA)
12.04%9.30%12.37%-42.86%-35.64%-36.31%
Return on Capital Employed (ROCE)
46.70%36.50%55.70%-313.80%-115.30%-69.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.91%-2.60%-11.94%-61.54%-50.90%-87.91%
FCF Yield
-2.24%-1.50%-5.53%-39.85%-38.09%-86.18%
Buyback Yield / Dilution
-14.32%-11.05%-81.54%-55.26%-129.76%-5.20%
SEC Filings: 10-K · 10-Q